Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis. / Hansen, Peter Riis; Iversen, Allan; Abdulla, Jawdat.

I: Journal of Invasive Cardiology, Bind 22, Nr. 6, 01.06.2010, s. 278-82.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Hansen, PR, Iversen, A & Abdulla, J 2010, 'Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis', Journal of Invasive Cardiology, bind 22, nr. 6, s. 278-82.

APA

Hansen, P. R., Iversen, A., & Abdulla, J. (2010). Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Journal of Invasive Cardiology, 22(6), 278-82.

Vancouver

Hansen PR, Iversen A, Abdulla J. Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Journal of Invasive Cardiology. 2010 jun. 1;22(6):278-82.

Author

Hansen, Peter Riis ; Iversen, Allan ; Abdulla, Jawdat. / Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis. I: Journal of Invasive Cardiology. 2010 ; Bind 22, Nr. 6. s. 278-82.

Bibtex

@article{6c115f6ac1af4d3785636b465d8ff6cf,
title = "Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis",
abstract = "Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). In the absence of results from large multicenter, randomized trials, we performed a systematic review and meta-analysis of available studies comparing IC to IV abciximab in these patients.",
author = "Hansen, {Peter Riis} and Allan Iversen and Jawdat Abdulla",
year = "2010",
month = jun,
day = "1",
language = "English",
volume = "22",
pages = "278--82",
journal = "Journal of Invasive Cardiology",
issn = "1042-3931",
publisher = "H M P Communications, LLC",
number = "6",

}

RIS

TY - JOUR

T1 - Improved clinical outcomes with intracoronary compared to intravenous abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a systematic review and meta-analysis

AU - Hansen, Peter Riis

AU - Iversen, Allan

AU - Abdulla, Jawdat

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). In the absence of results from large multicenter, randomized trials, we performed a systematic review and meta-analysis of available studies comparing IC to IV abciximab in these patients.

AB - Intracoronary (IC) administration of abciximab may increase local drug levels by several orders of magnitude compared to intravenous (IV) treatment and may improve clinical outcomes in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). In the absence of results from large multicenter, randomized trials, we performed a systematic review and meta-analysis of available studies comparing IC to IV abciximab in these patients.

M3 - Journal article

VL - 22

SP - 278

EP - 282

JO - Journal of Invasive Cardiology

JF - Journal of Invasive Cardiology

SN - 1042-3931

IS - 6

ER -

ID: 34077456